You may as well just blindfold yourself, and stick a pin in a calendar 📆.
My opinion is, is if DCVAX-L isn’t granted Marketing Approval shortly after the next CHM meeting, it’s it’s in trouble imho
Because unlike the Phase III Trial, there is no one on hand to help it across the line.
The posted results now standalone, whilst undergoing rigorous scrutiny by Regulatory Investigators, whose reason for being is just to find the smallest detail errors, or discrepancies in how pockets of data were derived at.
Imagine presenting your ear for examination. They will go in through you arse to get a closer look 👂 👀
Market Data 
Markets 
AI
